2022年08月12日

Health and Global Policy Institute (HGPI) held the August Study Group Session of the 11th semester of Health Policy Academy (HPA).

During the August study group session, we discussed the theme of “Improving catch-up vaccine uptake of the HPV vaccine.” The perspectives brought to the discussion through the session included concrete efforts needed to promote the catch-up vaccine uptake policy that came into effect in April 2022. As HPV vaccine uptake has long been a controversial topic that has been both promoted and withdrawn from promotion initiatives in the past, the discussion covered various related topics to tackle this public health challenge.

The 11th semester of HPA will be held over the next six months. It aims to provide participants with opportunities to learn basic knowledge and acquire skills for health policy through lectures by opinion leaders and interactive multi-stakeholder discussions among participants.

For more information on the 11th semester of HPA, please visit here.
This program is available only in Japanese.


Related contents held as part of the project

[Application Closed] Health Policy Academy the 11th Session *Application Deadline Extended to 31 March Noon (Opening in May 2022)
[Event Report] The 11th Semester of Health Policy Academy, Lecture 1 – Introduction (May 26, 2022)
[Event Report] The 11th Semester of Health Policy Academy, June Study Group Session (June 9, 2022)
[Event Report] The 11th Semester of Health Policy Academy, Lecture 2 – The History of Health Policy / Health Insurance System (June 23, 2022)
[Event Report] The 11th Semester of Health Policy Academy, July Study Group Session (July 7, 2022)
[Event Report] The 11th Semester of Health Policy Academy, Lecture 3 – Policy Making Process (July 21, 2022)

2022年08月12日

Health and Global Policy Institute (HGPI) has presented the results of a public opinion survey on mental health. The survey was conducted in March 2022 among 1,000 people selected by region, age, and sex in ratios in that correspond to the demographics of the total population of Japan.

Respondents were asked who they seek support from when experiencing mental distress and were allowed to select multiple options. Although over half selected “a family member or relative,” almost one-third (30%) said they have nobody to go to for support, showing that there is a limited number of people and places offering support to those who experience mental distress. Furthermore, less than 5% of respondents selected counseling services paid out-of-pocket, counseling services provided by employers, or public counseling services, which shows that these services are not available as options. Conversely, the most common response following “a family member or relative” and “a friend or acquaintance” was “my family doctor (other than a psychiatrist).” This suggests the importance of family doctors and the need for them to be able to provide their patients with appropriate treatments for mental health-related issues (Figure 1).



When asked about their social interactions outside of communities like the home, school, and the workplace, over 70% of respondents said they either had no such interactions or that the COVID-19 pandemic prevented them from maintaining connections with others. Given that more than 60% of respondents said they had been unable to secure a variety of opportunities for social interactions in the past, we can conclude that the COVID-19 pandemic further exacerbated their circumstances (Figure 2).



In FY2021, HGPI presented policy recommendations for the dissemination of Cognitive Behavioral Therapy (CBT). This survey showed that recognition toward the term “Cognitive Behavioral Therapy” was extremely low, at 16.1% (Figure 3).



There was low awareness toward the fact that mental health counseling services are available from local governments and healthcare institutions during emergencies, suggesting that it may be important to publicize the names of specific facilities offering these services in each community and to promote awareness toward them. Given the fact that this survey included pandemics in the definition of “emergencies,” and that there was an ongoing pandemic during the survey period, it is especially important that urgent steps are taken to build awareness toward these services (Figure 4).



When asked about their desire to use mental health counseling services during emergencies in the future, among those who said they have nobody to consult on mental health-related issues (approximately 30%, Figure 1), over two-thirds (69.4%) said they would like to receive counseling support remotely, either online (49.2%) or by telephone (28.6%). As physical and social factors may prevent people from connecting during emergencies, this finding suggests utilizing digital technology to deliver mental health care remotely will be effective during all types of emergencies and that the public has high expectations toward this area (Figure 5).



The results of the HGP public opinion survey on mental health show that approximately 30% of respondents said they have nobody to consult in times of mental distress. This suggests there is a certain number of people who are at risk of developing severe mental health issues because they are unable to act fast when experiencing mental health-related problems. At the same time, “my family doctor” was the third most-popular choice regarding parties to consult. This provides a key suggestion for future health policy. One option for the future might be to expand mental health support systems centered on family doctors.

In the area of disaster mental health care, many respondents expressed positive opinions regarding remote counseling systems, such as those using the internet. Now that it is the norm for everyone to carry a mobile device, this result may be able to provide a tailwind to efforts for making mental health care more accessible to all, even during normal times.

Historically, recognition toward CBT, which is used to treat many mental disorders including depression and schizophrenia, has been low. However, in a society where digitalization is continuously advancing, CBT is beginning to see wider usage, such as through phone apps for mental health care, and it is likely this field will be highly compatible with the public’s expectations toward the digitalization of care.

It has also been observed that digital devices helped people stay connected with each other during the COVID-19 pandemic, which suggests such devices can help people maintain mental well-being in times of emergency, such as during pandemics or after major earthquakes.

HGPI is engaged in various activities for mental health. For details regarding this project, please view our posts with the mental health tag at this link.

 

[References]

Ministry of Internal Affairs and Communications. “2021 White Paper on Information and Communications in Japan: ‘Livelihood and Economy Supported by Digital Technologies.’” (Last retrieved July 20, 2022)
National Center for Cognitive Behavior Therapy and Research. “What is Cognitive Behavioral Therapy?” (Last retrieved July 20, 2022)

2022年08月09日

Starting in FY2022, Health and Global Policy Institute (HGPI) launched a new project aiming to advance discussions on planetary health and contribute to better health for both the Earth and for people.

Until the 1980s, “planetary health” meant exactly what the term suggests: the health of the planet Earth. Around that time, researchers in the field of public health or organizations like the World Health Organization (WHO) were still unaware that climate change and the destruction of the Earth’s systems that support life could also impact human health. However, interest in climate change or our effects on the global environment within the field of healthcare has been growing in recent years, which led to a number of studies starting with the Rockefeller Foundation–Lancet Commission on Planetary Health in 2015. The Planetary Health alliance defined planetary health as, “a solution-oriented, interdisciplinary field and social movement concerned with assessing and mitigating the effects of human disruptions to Earth’s natural systems on human health and all species on Earth.” In 2014, the WHO published the “Quantitative Risk Assessment of the Effects of Climate Change on Selected Causes of Death, 2030s and 2050s,” the report estimates that allowing climate change and global warming to continue without effective measures to reduce greenhouse gas emissions will result in approximately 250,000 additional global deaths per year from 2030 and 2050 (96,000 from undernutrition, 60,000 from malaria, 48,000 from diarrhea, and 38,000 due to heat stroke-related causes). On the topic of greenhouse gasses, a key issue in planetary health, the healthcare sector has been found to be responsible for over 4% of global emissions. A report on emissions by industry in Korea found that emissions for the healthcare sector (not including the pharmaceutical industry) were equal to the food, beverage, and tobacco sector as well as the hospitality and dining sector, so there is a growing need for those in the healthcare sector to make considerations for the environment.

Given these circumstances, what countermeasures should be taken in and around the healthcare sector? The Sustainable Development Goals (SDGs) provide examples of countermeasures that have gained wide recognition among the public. The SDGs set targets for 17 areas for both developed and developing countries to meet by 2030 and include targets for health and the environment. While the concept of planetary health includes topics like the sustainability of relationships between humans and nature to create solutions in a manner that is similar to the SDGs, there is insufficient understanding in Japan toward the priority of planetary health and how the two are linked.

 

For the upcoming HGPI Seminar, we will host Professor and Executive Advisor to the President (Planetary Health) Chiho Watanabe of Nagasaki University who will talk about what planetary health is, how it is relevant to the SDGs, and issues for this topic in Japan. Nagasaki University was the first university in Japan to establish a school of planetary health, called the Interfaculty Initiative in Planetary Health, which is working to collaborate across the university to advance planetary health initiatives. In addition to his current activities, Professor Watanabe will also explain the significance of taking interdisciplinary action for planetary health instead of thinking of environmental, economic, and health issues separately.

Please note that this seminar is available in Japanese only. An English report of this event will be published in due course.

 


■Speaker:
Prof. Chiho Watanabe (Professor, School of Tropical Medicine and Global Health, Nagasaki University; Executive Advisor to the President (Planetary Health))

■Date and time:
Monday, September 5, 2022; 19:00-20:30 JST

■Venue:
Zoom Webinar

■Language:
Japanese

■Participation Fee:
Free

■Capacity:
500

 


■Profile:
Prof. Chiho Watanabe (Professor, School of Tropical Medicine and Global Health, Nagasaki University; Executive Advisor to the President (Planetary Health))
Professor Chiho Watanabe graduated from the University of Tokyo Graduate School of Medicine in 1989. He served as Professor of Human Ecology at the University of Tokyo Graduate School of Medicine from 2005 to 2017, as President of the National Institute for Environmental Studies from 2017 to 2021, and assumed his current position in 2021. He has been named Professor Emeritus of the University of Tokyo and is a Doctor of Health Science. His other positions include or have included President, Japanese Society of Health and Human Ecology (2017-present); Chairman, Society of Environmental Science (2021 -present); Associate Member, Section II, Science Council of Japan; former Third Vice President, Society for Human Ecology; and former Chair, Human Ecology Section, Ecological Society of America.


[Registration Closed] (Webinar) The 106th HGPI Seminar – The Construction of COVID-19 Vaccination Management Systems and Information Sharing in the Future (August 5, 2022) >

2022年08月08日

On August 24, 2022, the Health and Global Policy Institute (HGPI) Dementia Policy Project will host a public symposium titled, “Current Issues and Future Prospects for Idiopathic Normal Pressure Hydrocephalus (iNPH) Measures – Focusing on a Form of Dementia that Improves with Treatment.” It will use a hybrid in-person and online format with TKP Tokyo Station Otemachi Conference Center as the venue.

Projections show that the number of people living with dementia in Japan will soon exceed 7 million, and hopes are high for treatments that relieve the symptoms of dementia and address its underlying causes for better living later in life. Many diseases that cause dementia are considered difficult to treat, but iNPH is a form of dementia that improves with treatment. It is estimated that iNPH affects around 370,000 people, or about 5% of all people living with dementia. Furthermore, as pointed out in recent years, iNPH often occurs alongside Alzheimer’s disease, the most common cause of dementia, so the actual number of cases likely exceeds estimates. There are many potential benefits to delivering the appropriate treatments to people with iNPH. In addition to longer life expectancies, these include fall prevention and high returns in terms of health economics. As demonstrated by developments like the adoption of the “Research Survey on Structuring Healthcare for a Treatable Form of Dementia” as a Ministry of Health, Labour and Welfare Project for the Promotion of Well-Being for Elderly People, it is also gradually becoming a more important policy topic.

However, there are scattered issues that must be addressed before iNPH treatments can be delivered to as many people as possible to improve their symptoms and elevate their quality of life. First, despite the importance of early and accurate diagnosis, compared to the various other forms of dementia, it is difficult to say that awareness toward iNPH is high among civil society, healthcare providers, and long-term care providers. Second, iNPH can manifest as a broad variety of symptoms, and this requires collaboration across disciplines to address. After specialists from various fields examine a person to diagnose them with iNPH, they must work together with neurosurgeons who perform shunt procedures. Furthermore, to expand and enhance systems providing these treatments, there are various regional disparities that must be alleviated, so expectations are high for steps to achieve nationwide care equity.

To address these diverse issues with an all-of-society response, this symposium will gather multi-stakeholders including related healthcare and long-term care professionals, academia, Government representatives, and people living with iNPH. Together, we will deepen discussions on current issues in this area and necessary measures for addressing them.

Please note that this seminar is available in Japanese only. An English report of this event will be published in due course.

 


[Overview]

  • Date & Time:Wednesday, August 24, 2022; 17:00-19:00
  • Format: Hybrid format (with in-person and remote participation)
  • Venue: TKP Tokyo Station Otemachi Conference Center / Zoom webinar
  • Language: Japanese
  • Participation fee: Free


[Program]
(Titles omitted; in alphabetical order)

17:00-17:05 Opening remarks and explanatory introduction

  • Shunichiro Kurita (Manager, HGPI)

17:05-17:35 Keynote lecture: “The General Situation and Future Challenges for iNPH”

  • Hiroaki Kazui (Professor, Department of Neuropsychiatry, Kochi Medical School; Chairman, The Japanese Society of NPH)

17:35-18:05 Relay talk: “iNPH and Me: The Past, the Present, and the Future”

  • Michiyo Goto (Person living with iNPH)
  • Chifumi Iseki (Lecturer, Department of Internal Medicine III, Faculty of Medicine, Yamagata University)
  • Kazunari Ishii (Department Head, Diagnostic Radiology Division, Department of Radiology, Faculty of Medicine, Kindai University)
  • Madoka Nakajima (Associate Professor, Department of Neurosurgery, School of Medicine, Juntendo University)
  • Shigeki Yamada (Assistant Professor, Department of Neurosurgery, Shiga University of Medical Science)

18:10-18:55 Panel discussion: “Building Systems for Multidisciplinary Collaboration in Communities to Advance iNPH Measures”

Panelists:

  • Hiroaki Kazui (Professor, Department of Neuropsychiatry, Kochi Medical School; Chairman, The Japanese Society of NPH)
  • Syouzo Ohkouchi (Chief Long-Term Care Support Specialist, Care Plan Naruko; Care Creator)
  • Tatsuhiro Maeda (Assistant Director, Maeda Hospital, Yamamoto-Maeda Memorial Association; Director, Tokyo Metropolitan Cooperative Community Medical Center for Dementia; Director, NPH Center, Maeda Hospital)
  • Ken Nagata (Managing Director, Clinical Research Institute, Yokohama General Hospital; Director, Yokohama City Medical Center for Dementia)

Moderator:

  • Yukiko Kawata (Senior Associate, HGPI)

Designated remarks:

  • Aki Nakanishi (Deputy Director, Technical Officer (Medical Science), Division of Dementia Policy and Community-Based Long-Term Care Promotion, Health and Welfare Bureau for the Elderly, Ministry of Health, Labour and Welfare (MHLW))

18:55-19:00 Closing remarks

  • Seishi Kumano (Member, House of Councillors; Secretary, Parliamentary Association for Promoting Dementia Policies for an Inclusive Society)
2022年08月05日

Health and Global Policy Institute (HGPI) has released policy recommendations entitled, “Recommendations on the Development of Information Infrastructure and System Maintenance for Long-term Safety Assessment of Immunizations and Vaccines.”

The long-term safety assessment of immunizations and vaccines was considered an important issue in the policy recommendations released previously by the HGPI in June 2021 entitled, “A Life Course Approach to Immunization and Vaccination Policy – Five Perspectives and Recommended Actions.” The HGPI brought together experts with a shared sense of need to tackle this issue and summarized their discussions. The current recommendations are a summary of that discussion, including key points regarding future initiatives.

Through these recommendations, we hope that the safety evaluation of immunizations and vaccines will act as a safety net in immunization and vaccine policy, that discussions will expand in within the industry, government, academia and civil society to systematically promote the establishment of a system for safety evaluation, and that specific measures will be put into practice so that immunization and vaccine policies can create a mutual circle of benefit between individuals and society.

*Recommendations will be available in English in due course.


■Executive Summary

1 Establishing a Common Understanding of Immunization and Vaccine Safety Assessment

 1.1 Establishing a common understanding of the necessary information for and current systems of immunization and vaccine safety assessment

  • Establish a common understanding of the epidemiological information required to quantitatively and scientifically evaluate the safety immunizations and vaccines and the systems required to collect such information

2 Enhancing the Function of Passive Surveillance and Institutional Design of Active Surveillance

  2.1 Enhancing the function of the adverse reaction suspicion reporting system

  • Promote use of the adverse reaction suspicion reporting system for the prompt detection of abnormal adverse events and abnormal signals that should be examined for causal relationships with immunizations and vaccines
  • Enhance the function of passive surveillance through effective use of the adverse reaction suspicion reporting application, electronic reporting system, etc.

  2.2 Institutional design of active surveillance to complement the function of passive surveillance

  • Appropriate and prompt use of information based on the functional limitations of passive surveillance
  • Institutional design of active surveillance based on the functional limitations of passive surveillance

  2.3 Utilization of insurance user databases and development of medical information for active surveillance

  • Design and establish an active surveillance system that is aligned with the domestic healthcare system
  • Promote active surveillance systems that use insurance user databases that are based on medical expense statements

3 Development of Information Infrastructure that Supports Surveillance during Non-emergency Periods and Collaboration with Local Governments

  3.1 Maintenance and further promotion of immunization records

  • Promote the digitalization and compilation of immunization records in data bases within information sharing networks

  3.2 Utilization of information sharing network systems

  • Consider the compatibility between decentralized management as a security measure within information sharing network systems as well as the sharing of statistical information that contributes to safety assessments of immunizations and vaccines
  • Accelerate better information coordination and digitalization in the future based on a review of lessons learned in response to past emergencies

  3.3 Building a cooperative system among the national government, local governments, and other related organizations

  • Construct a cooperative system between the national government and local governments that contributes to the safety assessment of immunizations and vaccines, aimed at the linkage of national health insurance and other insurance user databases with immunization information
  • Promote trial efforts by local governments regarding information sharing within insurance user databases, the development of good practices, and the acceleration of studies on handling personal information
  • Utilize combined information from immunization information and health information and return such information to citizens through data visualization
     

4 Making Comprehensive Policy Decisions Based on Safety Assessments

  4.1 Establishment of a system for comprehensive policy judgement

  • Promote human resource development and the establishment of an assessment institution so that comprehensive policy decisions on immunization and vaccine policy can be made on a permanent basis

  4.2 Utilization of information sharing network systems

  • Promote human resource development and the dissemination of relevant and correct information, terminology, and the understanding of systems to contribute to effective communication with citizens regarding comprehensive policy decisions

 

■Working Group 3 “Information Systems” Members (Titles omitted; in alphabetical order by last name (as of 2021))

Working Group Members

  • Mugen Ujie (Chief of Travel Clinic / Director of Vaccination Support Center)
  • Hisashi Urushihara (Professor, Division of Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University)
  • Mizuho Oyama (Deputy Director, Planning and Finance Department and Chief Digital Office (CDO), Digital Strategy Office, Toda City; Advisor on Regional Informatization, Ministry of Internal Affairs and Communications
  • Satoshi Kamidani (Physician, Division of Pediatric Infectious Diseases & Vaccine and Treatment and Evaluation Units, Emory University; Visiting Scholar, Immunization Safety Office, Centers for Disease Control and Prevention (CDC))
  • Akinori Sugaya (Head Physician, Sugaya Children’s Clinic; Director, KNOW VPD Protect Our Children)
  • Keiko Tanaka-Taya (Director, Immunization Group, Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases)

Special Advisors

  • Keizo Takemi (Member, House of Councilors; Chairperson, Association for the Promotion of Improved Public Health through Vaccinations, Parliamentary Group for Vaccines and Prevention)
  • Noriko Furuya (Member, House of Representatives; Acting Chairperson, Association for the Promotion of Improved Public Health through Vaccinations, Parliamentary Group for Vaccines and Prevention)
2022年08月04日

An interview featuring Health and Global Policy Institute (HGPI) Senior Manager Prof. Haruka Sakamoto was published in COSMO.

Please access the article here

2022年07月29日

Health and Global Policy Institute (HGPI) held the third lecture of the 11th semester of Health Policy Academy (HPA).
At the third lecture, Hayato Kume (First Secretary , Embassy of Japan in the United States of America) provided the lecture entitled “Policy Making Process”. The first half of the lecture focused on principles and history of health policy. The second half covered a wide range of the recent topics including health policy innovations based on local data. In the Q&A session, students from diverse backgrounds actively asked questions, and it was a lively exchange of opinions that transcended industry and regional barriers.
 
The 11th semester of HPA will be held over the next six months. It aims to provide participants with opportunities to learn basic knowledge and acquire skills for health policy through lectures by opinion leaders and interactive multi-stakeholder discussions among participants.

For more information on the 11th semester of HPA, please visit here.
This program is available only in Japanese.


Related contents held as part of the project

[Application Closed] Health Policy Academy the 11th Session *Application Deadline Extended to 31 March Noon (Opening in May 2022)
[Event Report] The 11th Semester of Health Policy Academy, Lecture 1 – Introduction (May 26, 2022)
[Event Report] The 11th Semester of Health Policy Academy, June Study Group Session (June 9, 2022)
[Event Report] The 11th Semester of Health Policy Academy, Lecture 2 – The History of Health Policy / Health Insurance System (June 23, 2022)
[Event Report] The 11th Semester of Health Policy Academy, July Study Group Session (July 7, 2022)

2022年07月29日

AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) held the Seventh Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC). Participants discussed initiatives for the upcoming 2023 G7 Summit in Hiroshima and awareness building and educational support activities for AMR.

In light of the situation with COVID-19, this meeting was carried out primarily online. On-site participants were encouraged to keep sufficient physical distance from each other.

■Overview

Date: Monday, July 11, 2022
Organizer: AMR Alliance Japan (Secretariat: HGPI)


■Program

Greetings and Opening Remarks
Kazuhiro Tateda (President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University)

Report on Past Activities and Future Initiatives
Yui Kohno (AMR Alliance Japan Secretariat / Manager, HGPI)

Report on Working Group 3 reference materials
Shotaro Tsukamoto (AMR Alliance Japan Secretariat / Associate, HGPI)

Discussion

  • Introduction
    • Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare, “Direction and Outlook for Domestic AMR Control Measures”
    • International Affairs Division, Minister’s Secretariat, the Ministry of Health, Labour and Welfare, “Direction of AMR Control in the International Community and Outlook for the 2023 G7 Summit in Hiroshima”
    • Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat, “Developments in Updating the National Action Plan on AMR”
  • AMR Consortium Initiatives for the 2023 G7 Summit in Hiroshima and the Nikkei FT Communicable Diseases Conference
    • Formulating AMR Consortium policy recommendations
  • Questions on Working Group 3 reference materials for awareness building and educational support, and their future use

Facilitator:
Yui Kohno
(AMR Alliance Japan Secretariat / Manager, HGPI)

Comments on Next Steps and Closing Remarks
Ryoji Noritake (AMR Alliance Japan Secretariat / CEO, Board Member, HGPI)

 


■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)

January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
March 11, 2020 The First Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
March 19, 2020& The Second Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
March 24, 2020 The First Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
April 27, 2020 The Second Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
July 17, 2020 The Third Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
August 18, 2020 The Second Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
August 27, 2020 The Fourth Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
September 14, 2020 The First Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
September 23, 2020 The Third Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
October 7, 2020 The Fifth Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
October 8, 2020 The Third Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) 
November 7, 2020 The 7th NIKKEI FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC)
December 14, 2020 The Fourth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC)
March 12, 2021 The Fifth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC)
May 28, 2021 The Second Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC)
June 30, 2021 The Fourth Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
July 7, 2021 The Sixth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC)
October 28, 2021 The 8th NIKKEI FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC)
December 17, 2021 The Third Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC)

2022年07月27日

The World Health Organization (WHO) estimates that at least half of the world’s population does not have access to necessary health services and that every year 100 million people fall into poverty due to out-of-pocket medical expenses. Universal Health Coverage (UHC) aims to address this issue and ensure that all people have access to quality, affordable health services without financial hardship. As the core driver of Sustainable Development Goal (SDG) 3, UHC incorporates a range of health services from health promotion to prevention, treatment, rehabilitation, and palliative care. Over the past few years, the COVID-19 pandemic has had a major impact on health systems around the world and has demonstrated the interconnectedness between UHC and health emergencies. Global health security (GHS) is an essential element in realizing UHC and establishing strong and resilient health systems while enhancing pandemic preparedness and response. Effective GHS means that countries have resilient public health systems that prevent, detect, and respond to public health emergencies wherever they occur in the world.

At the same time, the emergence and spread of Antimicrobial Resistance (AMR) is one of the biggest issues in modern medicine and public health and is often referred to as a silent pandemic. According to the WHO, “AMR is one of the top 10 global public health threats facing humanity”. The ongoing COVID-19 pandemic is an example of what infectious diseases can do to existing health systems in the absence of an effective treatment. Like the ongoing pandemic, the silent AMR pandemic has a significant negative impact beyond the health sector. It threatens food security, the economy, and development, ultimately, diminishing progress made toward the achievement of the SDGs. In 2016, global leaders pledged to fight AMR at the 71st United Nations General Assembly (UNGA). This commitment at the highest level moved many countries to develop National Action Plans (NAPs) to combat AMR. However, the implementation of NAPs has proven to be challenging for many countries.

Dr. Tedros Ghebreyesus, Director-General of the WHO, stated that “progress toward UHC is vital for tackling the threat of AMR.” To date, most health systems have been developed on the assumption that effective and affordable antimicrobials would be readily available. However, the effectiveness of antimicrobials is no longer guaranteed, due to AMR. This places the sustainability of health systems in jeopardy and poses many economic and social risks. It is estimated that the cost of AMR in the European Union is 1.5 billion euros per year in health care costs and productivity losses. In Japan, the situation is the same, and there is research suggesting that even a 50% reduction in resistance toward gram-negative bacilli (one of the three most commonly isolated organisms) would lead to annual cost savings of between 2.5 to 6.4 billion yen. Without adequate stewardship of antimicrobial use, increased access associated with UHC could increase the risk of AMR. This means that strategies for strengthening health systems and for making progress towards UHC need to take AMR into account. 

The HGPI Special Seminar will bring together guests to discuss the connections between Universal Health Coverage, Global Health Security, and Antimicrobial Resistance. Global perspectives on their interconnectedness, including the inclusion of measures for AMR in international instruments for pandemic prevention, preparedness, and response currently under negotiation, will be discussed. Examples from Asia and Europe on addressing AMR and other global health issues using national health systems will then be introduced. The seminar aims to promote the importance of linking UHC, GHS, and AMR together in order to strengthen public health capacities and systems.

This webinar will be organized by Health and Global Policy Institute (HGPI), AMR Alliance Japan, and the Asia-Europe Foundation (ASEF).

 

 

[Overview]

  • Date & Time: Thursday, August 18, 2022, 18:00-19:30 (Tokyo) / 17:00-18:30 (Singapore) / 10:00-11:30 (London)
  • Format: Zoom Webinar
  • Participation fee: Free
  • Language: English (simultaneous interpretation to Japanese will be provided)
  • Hosted by: Health and Global Policy Institute (HGPI), AMR Alliance Japan, Asia-Europe Foundation (ASEF)


[Program]
(Japan Standard Time| Program is subject to change)

18:00-18:05 – Welcome and Introduction

  • Yui Kohno (Manager, Health and Global Policy Institute (HGPI))

18:05-18:10 – Opening Remarks

  • Toru Morikawa (Executive Director, Asia-Europe Foundation (ASEF))

18:10-18:20 – Introductory Comments

  • Riko Kimoto (Manager for International Public Health, Governance & Sustainable Development Department, Asia-Europe Foundation (ASEF))

    18:20-18:40 – Presentation (Tentative): Health System and AMR Subscription Model in the UK

    • Nick Crabb (Programme Director – Scientific Affairs, National Institute for Health and Care Excellence (NICE))

    18:40-19:00 – Presentation (Tentative): AMR NAP and Asian Pacific Collaboration

    • Eiji Hinoshita (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare)

    19:00–19:25 – Q&A Moderated by HGPI

    19:25–19:30 – Closing Remarks

    • Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)

    [Profile]

    Toru Morikawa (H.E. Ambassador, Executive Director, Asia Europe Foundation (ASEF)
    Ambassador MORIKAWA Toru (Japan) joined the Asia-Europe Foundation (ASEF) as its 8th Executive Director in August 2020. ASEF’s leadership alternates between Asia and Europe every four years. Ambassador MORIKAWA is a seasoned career diplomat bringing decades of experience and expertise to ASEF. His previous postings include serving as Minister, Deputy Head of Mission, Embassy of Japan in Iran; and Minister-Counsellor, Embassy of Japan in France where he was in charge of various cultural exchange initiatives. He has also worked in the areas of Media and Regional Economic Cooperation and has experience in cultivating and enhancing partnerships for projects with different organisations including the private sector. Ambassador MORIKAWA received his Bachelor’s Degree in Law from the University of Tokyo. He is fluent in Japanese, French, and English. He is married with two children.

    Eiji Hinoshita (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare)
    After graduating from Kyushu University, Faculty of Medicine, he joined the Department of Surgery II, Kyushu University. After getting Ph.D. degree at Kyushu University in 2000, he served as an Assistant Professor of Kyushu University in 2001. After joining in the Ministry of Health, Labour and Welfare in 2001, he served as Deputy Director-General of the Department of Welfare and Health, Niigata Prefectural Government, Director of the Office of International Food Safety, Councilor of the Permanent Mission of Japan to the United  Nations in New York, Director of the Office of International Cooperation, Director of the Global Health Policy Division, Ministry of Foreign Affairs, Director-General of the Bureau of International Health Cooperation, National Center for Global health and Medicine, Director, Infectious Disease Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare, and Director, Health and Medical Division, Bureau of Personnel and Education, Ministry of Defense. Dr. Hinoshita has also been a Visiting Professor of Nagasaki University.

    Nick Crabb (Programme Director – Scientific Affairs, National Institute for Health and Care Excellence (NICE))
    Nick had a 20-year career in analytical science, process technology and general management in the chemical, pharmaceutical and contract laboratory industries prior to joining NICE in 2010 as the associate director responsible for establishing and managing the Diagnostics Assessment Programme. In 2014 Nick was appointed to his current role where he oversees NICE Scientific Advice, the Science Policy and Research programme and NICE’s input to the European Network for Health Technology Assessment (EUnetHTA). Nick has broad scientific and policy interests relating to the evaluation of technologies and interventions to support the development of clinical, public health and social care guidance. His experience includes consideration of HTA issues arising from the availability of novel new products such as cell and gene therapies and work on methods issues relating to the evaluation of antimicrobials. Nick was also the co-chair of the evaluation and commissioning subgroup of the UK regenerative medicine expert group and led NICE’s contribution to a project on the assessment and appraisal of regenerative medicines that reported in 2016.

    Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)
    Dr. Kiyoshi Kurokawa is a professor emeritus at the National Graduate Institute for Policy Studies (GRIPS), Member of World Dementia Council (WDC), International Scientific Advisory Committee (ISAC), and Harvard T.H. Chan School of Public Health, John B. Little (JBL) Center for Radiation Sciences. After graduating from the University of Tokyo Faculty of Medicine, he served as a professor at the School of Medicine of UCLA (1979–1984), University of Tokyo (1989–1996), the dean of Tokai University School of Medicine (1996–2002), the president of the Science Council of Japan (2003–2006), the science advisor to the Prime Minister (2006–2008), World Health Organization (WHO) commissioner (2005–2009), Chair and Representative Director of Global Health Innovative Technology (GHIT: 2013.1-2018.6) and the executive member of many other national and international professional societies. He was also the chairman of the Fukushima Nuclear Accident Independent Investigation Commission by the National Diet of Japan from December 2011 to July 2012.

    Riko Kimoto (Manager for International Public Health, Governance &Sustainable Development Department)
    Riko Kimoto joined ASEF in April 2016. She leads ASEF Public Health Network from conceptualisation to implementation. Prior to joining ASEF, she gained extensive field NGO/volunteer experience in Latin America, collaborating with the local/international agencies such as the Ministry of Health and UNHCR, dealing with a wide range of issues in public health. Besides the Americas, she also worked in Africa as a project supervisor for hospital management. Since she has lived much of her adult life in countries other than her own, including Haitian Batey (village) in the rural Dominican Republic, she became very capable of adapting to different cultures and lifestyles, which she enjoys a lot. Riko has a Bachelor of Nursing degree from Australian Catholic University, and she is a qualified nurse with several years of clinical experience. She then obtained her Master’s degree in International Public Health (MIPH) from the University of Queensland. For MIPH, she conducted her research in Mexico, and her article was published in a professional journal afterwards.

    Yui Kohno (Manager, Health and Global Policy Institute)
    Ms. Yui Kohno is a graduate of the University of Sydney School of Public Health’s Faculty of Medicine and Health in Australia. After obtaining a Master of Health Policy degree from the University of Sydney, Ms. Kohno joined Health and Global Policy Institute. There, she is responsible for research and analysis of national and global policy challenges within and beyond the fields of Antimicrobial Resistance (AMR) and vaccination. Her activities include planning and coordinating conferences for better policy dialogue and discussion and engaging in public relations, outreach, and advocacy activities.

    2022年07月21日

    Alongside the presentation of the Health and Global Policy Institute (HGPI) Dementia Policy Project recommendations, titled “The Future of Dementia Policy 2022: Deepening Dementia Policies Centered on People Living with Dementia and their Families to Lead Global Society ,” a media briefing was held on July 13, 2022 at the press conference room of the Ministry of Health, Labour and Welfare.

    The meeting was opened with an overview of the history of HGPI’s Dementia Policy Project, followed by an explanation of the key points of HGPI’s new policy recommendations, “The Future of Dementia Policy 2022: Deepening Dementia Policies Centered on People Living with Dementia and their Families to Lead Global Society.”

    Moving forward, HGPI will continue presenting concrete recommendations and messages to address policy challenges through continuous discussions based on these recommendations with various stakeholders and that are centered on people living with dementia and their families.

    2022年07月20日

    <Key points>

    • Health and Global Policy Institute will begin a project for planetary health in which we will identify issues and share a direction for solutions in this field for all of Japan.
    • The concept of planetary health is based on initiatives the global community began to implement around the 1970s for environmental issues like climate change and the reduction of greenhouse gas emissions.
    • Starting around 2014 to 2015, the term “planetary health” has been used in the context of “the health hazards humanity will face and countermeasures we must take if we continue to view the Earth in anthropocentric terms.”

    Introduction

    As the various effects humanity has had on the Earth come back to impact our daily lives and our health, have you ever considered what sorts of actions we should take in the future? To help answer this question, Health and Global Policy Institute (HGPI) has launched an initiative to identify current issues and summarize next actions to respond to the effects that global climate change will have on human health from the perspective of planetary health.

    Although people might recognize the importance of working to address global problems like climate change and air pollution, there may be too few opportunities for them to comprehend the relationships between problems at that scale and individuals’ daily lives in an intuitive manner. As many reports from Japan and overseas tell us, global climate change already presents a number of hazards to our health. In 2015, an outbreak of Dengue fever in Tokyo centered around Yoyogi Park resulted in 108 people becoming infected.*1 Dengue fever is an infectious disease contracted from mosquitoes, and its distribution is said to be influenced by global warming.*2 During a heat wave in summer 2021, a record-high temperature of 49.6°C was recorded in Canada. In just a few days, this extreme heat took the lives of several hundred people due to heat stroke.

    As we see an increasing number of examples like these that make us feel how changes to the Earth’s systems directly affect our health, each country is starting to launch initiatives aiming to build sustainable relationships between the Earth and humanity. Examining yearly agendas of G7 and G20 meetings, which bring together leading countries for discussions on major worldwide challenges, we see the emergence of themes that emphasize the relationships between the environment and health in the field of atmosphere and the environment, as well approaches like the One Health Approach within the field of healthcare.

    Recent years have also seen the gradual spread of domestic and international initiatives for planetary health. At the Government of Japan, an assessment of health risks posed by climate change was included in a 2020 report from the Ministry of the Environment.*3 There is also a growing number of initiatives related to the links between health and the environment from academia and industry. Although industry, Government, academia, and civil society are each engaged in separate efforts for planetary health, nationwide issues have yet to be identified, and a shared national direction has yet to be set. HGPI aims to identify issues for Japan that require a multi-stakeholder response, to deepen understanding for this topic, and to communicate our findings in Japan and abroad while creating opportunities to move forward. In this, our first column on planetary health, we will introduce the background that led to the birth of planetary health as a concept.

    Past initiatives for responding to climate change around the world

    Figure 1: Global initiatives for climate change

    A sense of danger toward environmental issues first began to spread during the 1960s, when the economies of developed countries started growing rapidly in the wake of World War II. At the time, action was limited to each country’s domestic efforts undertaken on a per-country basis. Then, in 1972, the UN’s first discussions on environmental issues were held at the United Nations Conference on the Human Environment (UNCHE) in Stockholm. Several years later, in 1988, the UN established the Intergovernmental Panel on Climate Change (IPCC) with the goal of conducting scientific research on climate change. Then, at the “Earth Summit” (the United Nations Conference on Environment and Development, UNCED) which was held in Rio in 1992, the Rio Declaration on Environment and Development was signed and adopted by 154 countries with the objective of expanding the Stockholm Declaration. Together with Agenda 21, which was adopted simultaneously to implement its objectives, the Rio Declaration gave major impetus to national and local governments to draw up concrete action plans for addressing issues facing the environment.

    Can we see the limits of humanity’s ability to operate safely on the Earth? Introducing planetary boundaries

    Figure 2. Planetary boundaries (2022)

    In 2009, as countries began exploring the links among sustainable societies and the environment, a concept called “planetary boundaries” was described in a report in Ecology & Society.*4 It included a diagram showing the range of safe operating space on Earth for humanity, which has been influential to global movements including the Sustainable Development Goals (SDGs). Planetary boundaries describe upper limits in which humanity can continue developing and prospering over future generations if they go unsurpassed, while surpassing these boundaries carries the risk of rapid or irreversible changes to the environment. They identify the nine most important systems for maintaining our planet’s stability and resilience (its ability to recover naturally) and provide specific thresholds that can be used to assess and verify if boundaries have been crossed in each system. Since they were first presented in 2009, the planetary boundaries have been updated with new names and thresholds for several systems in 2015, 2017, and 2022. Incidentally, the 2022 update (Figure 2) shows five planetary boundaries in which humans can safely operate have already been crossed: (1) climate change, (4) loss of biosphere integrity, (5) altered biogeochemical cycles (7) land system change, and (9) introduction of novel entities into the biosphere in the form of chemical pollution.


    Promoting fair and effective global warming countermeasures with the Paris Agreement

    After the conclusion of the United Nations Framework Convention on Climate Change (UNFCCC), active discussions on effective methods of reducing greenhouse gas emissions have been held around the world. The Kyoto Protocol adopted in 1997 was the first agreement that legally obligated countries to reduce emissions, but its signatories were limited to developed countries. There were lingering challenges due to growing emissions from India and China, which were not included, as well as the withdrawal of the U.S. Later, in 2015, the Paris Agreement was signed or acceded to by all major emitters and included developing countries. Unlike the Kyoto Protocol, which legally obligated its parties to “achieve” target emission levels, the Paris Agreement requires each country to “submit” targets. This means the Paris Agreement takes a bottom-up approach in which all members create and submit their own targets and implement domestic policies, thereby advancing countermeasures for global warming in an effective, equitable manner.


    The human health effects of changes to the Earth’s systems is now becoming clear

    As global initiatives and analyses of environmental issues like those described above continue to advance, the relationships among changes in the Earth’s systems and human health effects was clearly demonstrated around 2014 to 2015. This has given momentum to the concept of planetary health, in which Earth and human health are viewed as interdependent.

    In 2014, the WHO presented its first report on the health impact of climate change.*5 In the scenario in which global warming continues at its current pace without effective measures to cut greenhouse gas emissions, it estimated there will be approximately 250,000 additional deaths per year from 2030 and 2050 compared to the scenario with no global warming. These include 96,000 from undernutrition, 60,000 from malaria, 48,000 from diarrhea, and 38,000 due to heat exposure among elderly people . It identified children in developing countries with particularly poor sanitation as the population most vulnerable to climate change. This report was a key analysis of how various factors caused by climate change will harm human health.

    At around the same time that report was released, in 2015, a research team assembled by prestigious medical journal The Lancet and the Rockefeller Foundation published a report titled “Safeguarding Human Health in the Anthropocene Epoch.”*6 It presented the concept that “Human health and civilization depend on the Earth’s natural systems, and we must gather environmental and epidemiological evidence and incorporate it into complex models if we are to understand those systems,”*7 forming the basic concept of planetary health in interdisciplinary terms. This concept of planetary health is said to have increased the prominence of more complex, realistic methods of understanding health and disease as they manifest on our unstable and fragile planet.

    The concept of “planetary health” is now expanding from academia and being communicated into various industries, such as when the Economist, one of the most influential international political and economic journals in the world, published a special report on planetary health in 2014.*8

    In our second column, we will take a look at global trends from the time the concept of planetary health was formed to today.

     

    References

    *1. National Institute of Infectious Diseases, Japan. 2015. “Regarding the Domestic Outbreak of Dengue Fever in Tokyo, Centered Around Yoyogi Park.” https://www.niid.go.jp/niid/ja/iasr-sp/2305-related-articles/related-articles-421/5449-dj4211.html
    *2. Ministry of the Environment. 2006. “Global Warming and Infectious Disease – What Do We Know Now?” https://www.env.go.jp/earth/ondanka/pamph_infection/full.pdf
    *3. Ministry of the Environment. 2020. “Regarding the Climate Change Impact Assessment Report.” https://www.env.go.jp/press/108790.html
    *4. Planetary Boundaries. Stockholm Resilience Centre. https://www.stockholmresilience.org/research/planetary-boundaries.html
    *5. WHO. Quantitative Risk Assessment of the Effects of Climate Change on Selected Causes of Death, 2030s and 2050s. https://www.who.int/publications/i/item/9789241507691
    *6. Whitmee, S., Haines, … & Yach, D. 2015. “Safeguarding Human Health in the Anthropocene Epoch: Report of The Rockefeller Foundation–Lancet Commission on Planetary Health.” The Lancet, 386 (10007), 1973-2028.
    *7. Nagasaki University (Supervised Translation). 2022. “Planetary Health: Protecting Nature to Protect Ourselves.” https://www.maruzen-publishing.co.jp/item/?book_no=304553. Maruzen Publishing Co., Ltd.
    *8. The Lancet and Rockefeller Foundation. 2014. “Planetary Health.” The Economist. https://www.rockefellerfoundation.org/wp-content/uploads/Planetary-Health-Special-Report_06.25.14.pdf

     

    Column author

    • Sayaka Honda (Intern, HGPI)
    • Shu Suzuki (Associate, HGPI)
    • Joji Sugawara (Senior Manager, HGPI)

    HGPI Policy Column (No.27) -from the Dementia Policy Team- >

    PageTop